tiprankstipranks
Standard BioTools (LAB)
NASDAQ:LAB

Standard BioTools (LAB) Income Statement

417 Followers

Standard BioTools Income Statement

Last quarter (Q4 2023), Standard BioTools's total revenue was $28.19M, an increase of 4.32% from the same quarter last year. In Q4, Standard BioTools's net income was $-19.78M. See Standard BioTools’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 106.34M$ 106.34M$ 97.95M$ 130.58M$ 138.14M$ 117.24M
Cost of Revenue
$ 58.68M$ 55.89M$ 52.55M$ -7.89M$ 54.82M$ 52.96M
Gross Profit
$ 47.66M$ 50.45M$ 45.39M$ 69.37M$ 83.33M$ 64.28M
Operating Expense
$ 114.06M$ 127.05M$ 214.15M$ -198.04M$ 134.36M$ 116.12M
Operating Income
$ -76.60M$ -76.60M$ -116.20M$ -67.46M$ -51.04M$ -51.84M
Net Non Operating Interest Income Expense
$ -4.57M$ -4.57M$ -4.33M$ -3.82M$ -3.57M$ -4.28M
Other Income Expense
$ -6.96M$ -6.96M$ 12.46M$ -482.00K$ 507.00K$ -10.59M
Pretax Income
$ -74.20M$ -74.20M$ -192.93M$ -63.66M$ -54.10M$ -66.70M
Tax Provision
$ 452.00K$ 452.00K$ -2.83M$ -4.42M$ -1.08M$ -1.92M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -74.66M$ -74.66M$ -130.17M$ -59.24M$ -53.02M$ -64.79M
Basic EPS
$ -0.95$ -0.94$ -2.43$ -0.78$ -0.74$ -0.97
Diluted EPS
$ -0.95$ -0.94$ -2.43$ -0.78$ -0.74$ -0.97
Basic Average Shares
$ 316.64M$ 79.16M$ 78.31M$ 75.79M$ 72.04M$ 66.78M
Diluted Average Shares
$ 316.64M$ 79.16M$ 78.31M$ 75.79M$ 72.04M$ 66.78M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----$ -0.30$ -0.36
Reported Normalized Diluted E P S
----$ -0.30$ -0.36
Rent Expense Supplemental
------
Total Expenses
$ 172.74M$ 182.94M$ 266.71M$ -205.93M$ 189.18M$ 169.08M
Net Income From Continuing And Discontinued Operation
$ -74.66M$ -74.66M$ -190.10M$ -59.24M$ -53.02M$ -64.79M
Normalized Income
$ -23.78M$ -45.06M$ -186.82M-$ -53.02M$ -53.12M
Interest Expense
----$ 3.57M$ 4.28M
EBIT
$ -69.64M$ -69.64M$ -188.60M$ -59.84M$ -50.53M$ -62.43M
EBITDA
$ -57.67M$ -57.67M$ -176.24M$ -47.30M$ -34.60M$ -47.14M
Currency in USD

Standard BioTools Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis